RUA BIOSCIENCE LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.069 NZD | -1.43% |
|
-8.00% | -42.50% |
| 05-07 | Rua Bioscience Extends Distribution Agreement with Germany's Nimbus Health | MT |
| 05-07 | Rua Bioscience Limited Extends Agreement with Nimbus Health in Germany | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Rua Bioscience Limited is a New Zealand-based medicinal cannabis company. The Company is engaged in the business of research and development, and pharmaceutical distribution and marketing. The Company is focused on breeding, cultivating, manufacturing, and supplying medicinal cannabis. The Company operates through one segment: research and development and the sale of pharmaceutical products in Germany and New Zealand. The Company also operates a full research laboratory in Gisborne, which enables cannabinoid testing, microscopic analysis, moisture analysis, sample preparation and extraction, solvent removal, viscosity measurements, and impurity testing.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -42.50% | 6.69M | |
| +42.38% | 6.26B | |
| -15.86% | 4.49B | |
| +6.36% | 3.29B | |
| -11.28% | 3.12B | |
| -3.23% | 2.5B | |
| +45.24% | 1.94B | |
| -7.89% | 1.68B | |
| -0.98% | 1.63B | |
| -11.32% | 1.56B |
- Stock Market
- Equities
- RUA Stock
- News Rua Bioscience Limited
- Rua Bioscience Secures Expanded Approval for Psilocybe Research, Phase 1 Clinical Protocol Clearance
